Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL2L1 anticorps (Biotin)

L’anticorps Souris Monoclonal anti-BCL2L1 a été validé pour FACS. Il convient pour détecter BCL2L1 dans des échantillons de Humain. Il y a 1 publication disponible.
N° du produit ABIN135023

Aperçu rapide pour BCL2L1 anticorps (Biotin) (ABIN135023)

Antigène

Voir toutes BCL2L1 Anticorps
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reactivité

  • 221
  • 129
  • 114
  • 50
  • 25
  • 12
  • 10
  • 9
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Humain

Hôte

  • 156
  • 89
  • 1
Souris

Clonalité

  • 142
  • 104
Monoclonal

Conjugué

  • 120
  • 26
  • 11
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BCL2L1 est conjugé à/à la Biotin

Application

  • 164
  • 84
  • 63
  • 54
  • 53
  • 33
  • 28
  • 28
  • 25
  • 25
  • 21
  • 11
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Clone

7B2-5
  • Specificité

    Human/Mouse/Rat/Rhesus Bcl-xL

    Attributs du produit

    Mouse Anti-Bcl-xL-BIOT

    Immunogène

    Recombinant human Bcl-xS

    Isotype

    IgG3
  • Indications d'application

    • Applications: FC - Quality tested , IHC-PS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , IP - Reported in literature , ELISA - Reported in literature
    • Working Dilutions: Flow Cytometry FITC and BIOT conjugates 3 g/106 cells PE conjugate 0.3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 1 g/mL

    Volume d'échantillon

    1 mL

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    0.1 mg in 1.0 mL PBS/Sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect conjugated products from light.
    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Stock

    4 °C

    Stockage commentaire

    Store at 2-8°C
  • Gottschalk, Boise, Oltvai, Accavitti, Korsmeyer, Quintáns, Thompson: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." dans: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).

  • Antigène

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Autre désignation

    Bcl-xL

    Sujet

    Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment. Bcl-2 and one of its homologues, Bcl-xL, protect cells from apoptosis, while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis. Bcl-xL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. In contrast, Bad and Bax inhibit the protective functions of Bcl-xL and Bcl-2, respectively. Although heterodimerization between Bcl-xL/Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-xL and Bcl-2, other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity.

    Pathways

    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Vous êtes ici:
Chat with us!